NeueHealth, Inc.
NeueHealth, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Series B Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Segment Discontinued Operations | -1 | 335 | 345 | -4 | 342 | 2 | 700 | - | 600 | - | - | - | |||||
Disposal Group Heldforsale Not Discontinued Operat… | - | - | - | 1 | 4 | - | - | - | - | - | - | - | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 132 | 138 | 83 | 110 | 133 | 113 | 87 | 113 | 108 | 383 | 217 | 1,606 | |||||
Short Term Investments | 14 | 7 | 10 | 9 | 9 | 0 | 6 | 0 | 0 | 12 | 1 | 300 | |||||
Accounts Receivable Net Current | 53 | 42 | 37 | 43 | 36 | 40 | 39 | 33 | 28 | 125 | 20 | 120 | |||||
Assets Of Disposal Group Including Discontinued Op… | 90 | 94 | 173 | 128 | 142 | 149 | 823 | 1,369 | 3,031 | 2,226 | 3,187 | - | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | - | - | - | 6 | 8 | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 30 | 39 | 37 | 33 | 31 | 26 | 18 | 47 | 61 | 143 | 47 | 377 | |||||
Assets Current | 640 | 788 | 435 | 589 | 786 | 974 | 1,089 | 1,912 | 3,851 | 3,771 | 3,571 | 2,638 | |||||
Long Term Investments | - | - | - | - | - | - | 0 | 0 | 0 | 4 | 5 | 866 | |||||
Other Assets | |||||||||||||||||
Property Plant And Equipment Net | 12 | 11 | 11 | 12 | 12 | 13 | 14 | 18 | 18 | 41 | 21 | 48 | |||||
Intangible Assets Net Excluding Goodwill | 66 | 69 | 71 | 74 | 76 | 90 | 93 | 96 | 99 | 242 | 105 | 263 | |||||
Goodwill | - | - | - | - | - | - | 0 | 0 | 401 | 760 | 401 | 761 | |||||
Other Assets Noncurrent | 26 | 28 | 27 | 22 | 24 | 28 | 29 | 30 | 23 | 30 | 32 | 36 | |||||
Disposal Group Including Discontinued Operation As… | - | - | - | - | - | - | 0 | 0 | 0 | - | 529 | - | |||||
Assets Noncurrent | 104 | 107 | 110 | 107 | 112 | 131 | 137 | 144 | 542 | 1,077 | 1,094 | 1,974 | |||||
Assets | 744 | 896 | 544 | 697 | 897 | 1,105 | 1,225 | 2,056 | 4,393 | 4,848 | 4,665 | 4,612 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Liability For Claims And Claims Adjustment Expense | 98 | 114 | 124 | 124 | 137 | 158 | 158 | 170 | 180 | 187 | 116 | 110 | |||||
Accounts Payable Current | 5 | 5 | 6 | 6 | 9 | 6 | 12 | 11 | 18 | 34 | 19 | 111 | |||||
Unearned Premiums | - | - | - | - | - | - | - | - | - | 139 | 0 | 196 | |||||
Short Term Borrowings | 1 | 1 | 2 | 0 | 0 | 0 | 304 | 354 | 304 | 304 | 304 | 304 | |||||
Liabilities Of Disposal Group Including Discontinu… | - | - | - | - | - | 345 | 700 | 975 | 2,585 | 2,226 | 3,157 | - | |||||
Other Liabilities Current | 70 | 75 | 79 | 90 | 79 | 85 | 80 | 87 | 73 | 131 | 97 | 201 | |||||
Liabilities Current | 908 | 1,064 | 710 | 872 | 1,044 | 1,260 | 1,391 | 1,831 | 3,635 | 4,012 | 3,693 | 3,251 | |||||
Long Term Debt | - | - | - | 120 | 118 | 66 | 66 | - | - | - | 0 | - | |||||
Long Term Debt Noncurrent | 212 | 207 | 203 | - | - | - | 66 | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 16 | 17 | 18 | 17 | 18 | 21 | 22 | 31 | 29 | 32 | 32 | 33 | |||||
Liabilities | 1,137 | 1,289 | 930 | 1,009 | 1,180 | 1,347 | 1,480 | 1,861 | 3,664 | 4,044 | 3,725 | 3,284 | |||||
Redeemable Noncontrolling Interest Equity Carrying… | 56 | 48 | 49 | 118 | 104 | 99 | 89 | 327 | 245 | 224 | 220 | 211 | |||||
Temporary Equity Carrying Amount Attributable To P… | 920 | 920 | 920 | 920 | 920 | 920 | 920 | 920 | 920 | 920 | 920 | 747 | |||||
Statement Of Stockholders… | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 3,107 | 3,105 | 3,099 | 3,101 | 3,088 | 3,075 | 3,056 | 3,038 | 3,021 | 3,006 | 2,972 | 2,940 | |||||
Retained Earnings Accumulated Deficit | -4,464 | -4,454 | -4,443 | -4,440 | -4,382 | -4,324 | -4,308 | -4,078 | -3,444 | -3,331 | -3,156 | -2,477 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -1 | -2 | -4 | -82 | |||||
Treasury Stock Value | - | - | - | - | - | - | - | - | - | - | - | -12 | |||||
Treasury Stock Common Value | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | -12 | - | |||||
Stockholders Equity | -1,369 | -1,361 | -1,355 | -1,351 | -1,307 | -1,261 | -1,264 | -1,053 | -436 | -340 | -200 | 358 | |||||
Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | - | - | 100 | |||||
Temporary Equity Shares Issued | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Liabilities And Stockholders Equity | 744 | 896 | 544 | 697 | 897 | 1,105 | 1,225 | 2,056 | 4,393 | 4,848 | 4,665 | 4,612 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 10 | 14 | 9 | 8 | 7 | 6 | 7 | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Temporary Equity Shares Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | |||||
Common Stock Shares Issued | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 636 | 8 | 630 | |||||
Shares Outstanding | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 636 | 8 | 630 | |||||
Treasury Stock Shares | - | - | - | - | - | - | - | - | - | - | - | 3 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | - | |||||
Stockholders Equity Note Stock Split Conversion Ra… | - | - | - | - | - | - | 0 | 0 | - | - | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.70 | 0.74 | 0.61 | 0.68 | 0.75 | 0.77 | 0.78 | 1.04 | 1.06 | 0.94 | 0.97 | 0.81 | |||||
| Quick Ratio | 0.67 | 0.70 | 0.56 | 0.64 | 0.72 | 0.75 | 0.77 | 1.02 | 1.04 | 0.90 | 0.95 | 0.70 | |||||
| Working Capital | -268.53M | -275.85M | -275.58M | -283.01M | -258.62M | -285.09M | -302.33M | 81.46M | 216.04M | -240.47M | -122.53M | -613.45M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -0.83 | -0.95 | -0.69 | -0.75 | -0.90 | -1.07 | -1.17 | -1.77 | -8.41 | -11.89 | -18.58 | 9.16 | |||||
| Interest Coverage TTM | -1.19 | -3.64 | -5.74 | -5.24 | -20.13 | -16.65 | -15.10 | -17.15 | -7.28 | -13.07 | -28.76 | -39.80 | |||||
| Debt Ratio | 1.53 | 1.44 | 1.71 | 1.45 | 1.31 | 1.22 | 1.21 | 0.91 | 0.83 | 0.83 | 0.80 | 0.71 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.77 | 0.77 | 1.06 | 0.94 | 0.49 | 0.46 | 0.39 | 0.15 | 0.10 | 0.04 | 0.18 | -0.09 | |||||
| Days Sales Outstanding TTM | 25.82 | 19.29 | 14.75 | 10.67 | 9.03 | 22.23 | 9.22 | 56.45 | 67.30 | 260.86 | 28.78 | -104.32 | |||||
| Receivables Turnover TTM | 14.14 | 18.92 | 24.75 | 34.20 | 40.41 | 16.42 | 39.58 | 6.47 | 5.42 | 1.40 | 12.68 | -3.50 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -15.24 | -22.52 | -22.65 | -63.56 | -125.19 | -136.22 | -159.14 | -197.86 | -170.53 | -188.00 | -190.04 | -202.72 | |||||
| Free Cash Flow Per Share TTM | -8.25 | -11.53 | -15.26 | -52.14 | -252.16 | -267.53 | -343.15 | -285.96 | -154.60 | -112.63 | 26.31 | -8.97 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | -7.28% | 8.59% | 41.47% | 71.09% | 84.28% | 97.54% | 96.71% | 93.26% | 93.96% | 89.64% | 98.29% | 102.06% | |||||
| Operating Profit Margin TTM | -4.74% | -10.57% | -11.47% | -9.57% | -44.33% | -40.94% | -49.71% | -115.62% | -43.96% | -135.38% | -49.09% | 82.11% | |||||
| Net Profit Margin TTM | -21.75% | -24.98% | -19.89% | -40.64% | -80.45% | -81.14% | -109.05% | -318.76% | -290.25% | -791.72% | -199.06% | 415.13% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -51.02% | -43.04% | -19.31% | 161.60% | 174.56% | 623.59% | 54.53% | -228.82% | -29.26% | -71.41% | - | - | |||||
| Net Income Growth (1Y) | -86.75% | -82.46% | -85.28% | -66.65% | -23.90% | -25.84% | -15.34% | -1.08% | -13.29% | 9.20% | - | - | |||||
| EPS Growth (1Y) | -87.82% | -83.47% | -85.77% | -67.88% | -26.58% | -27.54% | -16.26% | -2.40% | -14.34% | 8,598.13% | - | - | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -74.05M | -98.84M | -125.55M | -431.86M | -2.08B | -2.16B | -2.73B | -2.28B | -1.23B | -889.14M | 207.02M | -70.58M | |||||
| Net Debt | 502.00K | -16.43M | 19.21M | -106.16M | -143.79M | -183.03M | -4.93M | -369.47M | -1.06B | -1.70B | -1.63B | -1.30B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
NeueHealth, Inc. (NEUE) — SEC Financial Statements & Analysis
NeueHealth, Inc. (NEUE) is a hospital & medical service plans company, incorporated in DE. NeueHealth, Inc. trades on None as: NEUE. Based on its latest SEC filing (Form 10-Q, period ending 2025-06-30), NeueHealth, Inc. reported a -51.02% year-over-year revenue growth, a Gross Profit Margin of -7.28% (TTM), a Debt-to-Equity ratio of -0.83x. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -51.02%
- Gross Profit Margin TTM
- -7.28%
- Debt To Equity
- -0.83x
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NeueHealth, Inc. in?
NeueHealth, Inc. (NEUE) operates in the Hospital & Medical Service Plans industry.
What exchange does NEUE trade on?
NeueHealth, Inc. (NEUE) trades on the None.
Where is NeueHealth, Inc. incorporated?
NeueHealth, Inc. is incorporated in DE.